Association between IL-6 and prognosis of gastric cancer: a retrospective study

Background: Gastric cancer (GC) is one of the common and fatal cancers. Even though the Tumor, Node, Metastasis (TNM) staging system is the most classical staging system recognized worldwide, it has been controversial because there are various factors affecting the prognosis of GC patients. Objectiv...

Full description

Bibliographic Details
Main Authors: Panping Liang, Yuexin Zhang, Tianyuchen Jiang, Tao Jin, Zhengwen Chen, Zedong Li, Zehua Chen, Fengjun He, Jiankun Hu, Kun Yang
Format: Article
Language:English
Published: SAGE Publishing 2023-11-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848231211543
_version_ 1797582970138132480
author Panping Liang
Yuexin Zhang
Tianyuchen Jiang
Tao Jin
Zhengwen Chen
Zedong Li
Zehua Chen
Fengjun He
Jiankun Hu
Kun Yang
author_facet Panping Liang
Yuexin Zhang
Tianyuchen Jiang
Tao Jin
Zhengwen Chen
Zedong Li
Zehua Chen
Fengjun He
Jiankun Hu
Kun Yang
author_sort Panping Liang
collection DOAJ
description Background: Gastric cancer (GC) is one of the common and fatal cancers. Even though the Tumor, Node, Metastasis (TNM) staging system is the most classical staging system recognized worldwide, it has been controversial because there are various factors affecting the prognosis of GC patients. Objectives: The study aims to evaluate the relationship between interleukin-6 (IL-6) and several clinical indicators and construct a prognostic model to better predict the prognosis of GC. Design: A retrospective study. Methods: Data of 249 patients with GC diagnosed in GC center of West China Hospital were collected. Clinicopathological characteristics were analyzed to determine whether there were differences between IL-6 HIGH group and IL-6 LOW group. Besides, the association between the two groups and tumor marker levels was clarified. The K-M curves of 3- and 5-year were plotted with log-rank test. Afterward, we conducted univariate and multivariate analysis and a predicting nomogram. Significantly, C-index, and calibration were used to evaluate the value of nomogram in predicting prognosis. Results: The overall survival of GC in the IL-6 HIGH and IL-6 LOW groups were 47.8 months (95% CI: 42.1–53.4) and 57.9 months (95% CI: 54.1–61.7), respectively, with significant differences ( p  = 0.0046). Average tumor size of GC ( p  = 0.000) and nerve invasion ( p  = 0.018) were statistically significant between two groups. Multivariate analysis revealed that the factors affecting prognosis were IL-6 (<5.51 and ⩾5.51 pg/ml) (Hazard Ratio(HR): 1.665, 95% CI: 1.026–2.703, p  = 0.039), N stage (HR: 1.336, 95% CI: 1.106–1.615, p  = 0.003), and T stage (HR: 1.268, 95% CI: 0.998–1.611, p  = 0.052), which were included in the nomogram with a C-index of 0.71. The current data calculated TNM staging C-index was 0.68, and the p -value for the difference between the two models was 0.08. Internal validation revealed that the predicted overall survival did not differ significantly from the actual observed patient survival. Conclusion: The differential expression of IL-6 has a tendency to differentiate the prognosis of GC patients. IL-6, N stage, and T stage are independent prognostic factors, and the new survival prognostic model consisting of the above three indicators is better than the classical TNM staging system. Trial registration: This study is a retrospective study, which does not require clinical registration.
first_indexed 2024-03-10T23:29:09Z
format Article
id doaj.art-e2746457e59f4e24a3105bd3ed229b76
institution Directory Open Access Journal
issn 1756-2848
language English
last_indexed 2024-03-10T23:29:09Z
publishDate 2023-11-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Gastroenterology
spelling doaj.art-e2746457e59f4e24a3105bd3ed229b762023-11-19T07:34:13ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-28482023-11-011610.1177/17562848231211543Association between IL-6 and prognosis of gastric cancer: a retrospective studyPanping LiangYuexin ZhangTianyuchen JiangTao JinZhengwen ChenZedong LiZehua ChenFengjun HeJiankun HuKun YangBackground: Gastric cancer (GC) is one of the common and fatal cancers. Even though the Tumor, Node, Metastasis (TNM) staging system is the most classical staging system recognized worldwide, it has been controversial because there are various factors affecting the prognosis of GC patients. Objectives: The study aims to evaluate the relationship between interleukin-6 (IL-6) and several clinical indicators and construct a prognostic model to better predict the prognosis of GC. Design: A retrospective study. Methods: Data of 249 patients with GC diagnosed in GC center of West China Hospital were collected. Clinicopathological characteristics were analyzed to determine whether there were differences between IL-6 HIGH group and IL-6 LOW group. Besides, the association between the two groups and tumor marker levels was clarified. The K-M curves of 3- and 5-year were plotted with log-rank test. Afterward, we conducted univariate and multivariate analysis and a predicting nomogram. Significantly, C-index, and calibration were used to evaluate the value of nomogram in predicting prognosis. Results: The overall survival of GC in the IL-6 HIGH and IL-6 LOW groups were 47.8 months (95% CI: 42.1–53.4) and 57.9 months (95% CI: 54.1–61.7), respectively, with significant differences ( p  = 0.0046). Average tumor size of GC ( p  = 0.000) and nerve invasion ( p  = 0.018) were statistically significant between two groups. Multivariate analysis revealed that the factors affecting prognosis were IL-6 (<5.51 and ⩾5.51 pg/ml) (Hazard Ratio(HR): 1.665, 95% CI: 1.026–2.703, p  = 0.039), N stage (HR: 1.336, 95% CI: 1.106–1.615, p  = 0.003), and T stage (HR: 1.268, 95% CI: 0.998–1.611, p  = 0.052), which were included in the nomogram with a C-index of 0.71. The current data calculated TNM staging C-index was 0.68, and the p -value for the difference between the two models was 0.08. Internal validation revealed that the predicted overall survival did not differ significantly from the actual observed patient survival. Conclusion: The differential expression of IL-6 has a tendency to differentiate the prognosis of GC patients. IL-6, N stage, and T stage are independent prognostic factors, and the new survival prognostic model consisting of the above three indicators is better than the classical TNM staging system. Trial registration: This study is a retrospective study, which does not require clinical registration.https://doi.org/10.1177/17562848231211543
spellingShingle Panping Liang
Yuexin Zhang
Tianyuchen Jiang
Tao Jin
Zhengwen Chen
Zedong Li
Zehua Chen
Fengjun He
Jiankun Hu
Kun Yang
Association between IL-6 and prognosis of gastric cancer: a retrospective study
Therapeutic Advances in Gastroenterology
title Association between IL-6 and prognosis of gastric cancer: a retrospective study
title_full Association between IL-6 and prognosis of gastric cancer: a retrospective study
title_fullStr Association between IL-6 and prognosis of gastric cancer: a retrospective study
title_full_unstemmed Association between IL-6 and prognosis of gastric cancer: a retrospective study
title_short Association between IL-6 and prognosis of gastric cancer: a retrospective study
title_sort association between il 6 and prognosis of gastric cancer a retrospective study
url https://doi.org/10.1177/17562848231211543
work_keys_str_mv AT panpingliang associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT yuexinzhang associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT tianyuchenjiang associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT taojin associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT zhengwenchen associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT zedongli associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT zehuachen associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT fengjunhe associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT jiankunhu associationbetweenil6andprognosisofgastriccanceraretrospectivestudy
AT kunyang associationbetweenil6andprognosisofgastriccanceraretrospectivestudy